Robust allāround performance; BUY
Our View:
SRF reported a robust, above estimated, operating profit of Rs 8.8bn (+62% YoY; +30% QoQ), during the quarter, backed by strong operating earnings, across its business segments. With the 9MFY22 Ebitda of Rs 20.7bn, SRF has already clocked in operating profits higher than entire FY21, in the nine month period.
Chemicals business, benefited from strong revenue traction from both domestic and exports markets, led by demand from agrochemicals m...
Buy SRF Ltd For Target Rs.2,965 - Yes Securities